SCHEMBL2772191

SCHEMBL2772191

O=C(Nc1ccccc1Cl)N(S)c1noc2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 5/20 0.60
SMN1; SMN2 Q16637 5/20 0.44
TP53 P04637 2/20 0.44
RAB9A P51151 3/20 0.43
MAOB P27338 1/20 0.43
NPC1 O15118 1/20 0.43
STAT3 P40763 1/20 0.40
STAT1 P42224 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
HTT P42858 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
EPHB3 P54753 1/20 0.39
CYP1A2 P05177 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
POLB P06746 1/20 0.37
ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2768263 0.85 EPHX2 (0.49) HIF1ASMN1; SMN2TP53RAB9ANPC1
SCHEMBL2769370 0.82 MAPT (0.41) HIF1AKMT2AMAPT
SCHEMBL2770757 0.82 EPHX2 (0.52) HIF1ASMN1; SMN2TP53RAB9ANPC1
SCHEMBL2769321 0.82 HIF1A (0.56) HIF1ASMN1; SMN2TP53RAB9ANPC1
SCHEMBL2770372 0.81 MEN1 (0.45) HIF1ASMN1; SMN2RAB9ANPC1MEN1
SCHEMBL2769009 0.79 NPC1 (0.47) HIF1ASMN1; SMN2TP53RAB9ANPC1
SCHEMBL2768687 0.79 HIF1A (0.41) HIF1ASMN1; SMN2TP53RAB9ANPC1
SCHEMBL2771191 0.78 SMN1; SMN2 (0.50) HIF1ASMN1; SMN2TP53RAB9AMAOB
SCHEMBL2768329 0.76 HIF1A (0.63) HIF1ASMN1; SMN2RAB9AMAOBNPC1
SCHEMBL2770290 0.76 NPC1 (0.45) HIF1ASMN1; SMN2TP53RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881967-B1 SUBSTITUTED BENZO(D)ISOXAZOL-3-YL AMINE COMPOUNDS AS ANALGESICS GRUENENTHAL GMBH (DE) 2010-04-28 EP claimed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US claimed
US-7696238-B2 Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics GRUENENTHAL GMBH (DE) 2010-04-13 US disclosed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics KCNQ1, KCNQ2, KCNQ3 HIF1A 1664/4885SMN1; SMN2 1349/4885TP53 4784/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.